Mayne Pharma.

PositionEASTERN BRIEFS: GREENVILLE

Mayne Pharma will pay $652 million to acquire 37 approved drugs and five that are awaiting FDA approval from drugmakers Teva Pharmaceutical Industries and Allergan. Manufacturing of 11 of the new products will be transferred to the Australian...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT